Lipomics raises $2.8M for metabolic diagnostics

Lipomics, a West Sacramento, Calif., biotech, raised $2.8 million in a fourth funding round, VentureWire reports (subscription required). Among the investors was DFJ Frontier.

Lipomics is developing diagnostic tests for important measures of metabolic function that may be useful in managing and treating conditions such as diabetes, obesity, and heart disease.